Periostin in Melanoma and Other Cancers
Author Information
Author(s): Tilman Gaƫlle, Mattiussi Marina, Brasseur Francis, van Baren Nicolas, Decottignies Anabelle
Primary Institution: Cellular Genetics Unit, de Duve Institute, Catholic University of Louvain
Hypothesis
Is periostin expression a reliable marker for tumor progression in melanoma and other cancers?
Conclusion
Periostin is overexpressed in about 60% of melanoma metastases, suggesting its role in cancer progression.
Supporting Evidence
- Periostin expression levels are highly variable in normal tissues and tumors.
- Strong periostin overexpression is mostly detected in tumors from pancreas and liver.
- In melanoma, periostin is not expressed in primary tumors but is overexpressed in about 60% of metastatic tumors.
- Both stromal cells and melanoma cells contribute to periostin production.
- Higher periostin levels correlate with increased tumor thickness in melanoma.
Takeaway
This study found that a protein called periostin is made by both cancer cells and surrounding cells in melanoma, and it might help the cancer grow.
Methodology
Quantitative RT-PCR was used to assess periostin gene expression in various tissues and melanoma samples.
Potential Biases
Potential bias in sample selection and variability in periostin expression across different tumor types.
Limitations
The study's findings may not apply universally to all tumor types due to variability in periostin expression.
Participant Demographics
The study included human tissue samples from melanoma patients and normal tissues.
Statistical Information
P-Value
0.003
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website